New Delhi [India], June 28 (ANI): The Drugs Controller General of India (DCGI) has approved two doses of Pune-based Gennova Biopharmaceuticals' mRNA COVID-19 vaccine for restricted use in emergency situations for beneficiaries aged above 18 years age group.
New Delhi [India], June 28 (ANI): The Subject Expert Committee (SEC) in a meeting held on Friday recommended Emergency Use Authorisation (EUA) for India's first mRNA COVID-19 vaccine, sources told ANI on Tuesday.
New Delhi [India], May 16 (ANI): Dr N Madhusudan Rao, CEO-Atal Incubation Centre at Centre for Cellular and Molecular Biology (CCMB) on Monday said that India has developed mRNA technology against the COVID-19.
New Delhi [India], May 15 (ANI): Even after clearance for stockpiling more than 21 lakh doses of m-RNA COVID-19 vaccine doses from the Central Drugs Laboratory (CDL) Kasauli, the Pune-based pharma company, Gennova has been alleged to have violated the clinical trial protocol.
New Delhi [India], May 14 (ANI): Even as Central Drugs Laboratory (CDL) Kasauli has already cleared more than 21 lakh doses of m-RNA Covid-19 vaccine doses for stockpiling, the Pune-based pharma company Gennova is facing allegations of violations of the clinical trial protocol.
New Delhi [India], May 13 (ANI): The Central Drugs Laboratory (CDL), Kasauli has cleared more than 21 lakh mRNA COVID-19 vaccine doses for stockpiling, the sources told ANI.
Beijing [China], May 3 (ANI): President of the European Union Chamber of Commerce in China revealed that in a closed-door meeting with top-Communist Party of China (CPC) officials, they have made it clear that they know the dangers of the "Zero-COVID" policy and its impact on the economy but
New Delhi [India], April 13 (ANI): Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.
Hyderabad (Telangana) [India], April 4 (ANI): Hyderabad-based vaccine manufacturer Biological E on Monday announced that it has been selected as a recipient of mRNA technology from the World Health Organisation (WHO) technology transfer hub.
New Delhi [India], March 18 (ANI): Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III trials data of India's first mRNA COVID vaccine to the regulator Drugs Controller General of India (DCGI) on Friday, said sources.
Washington [US], March 4 (ANI): The research group at the University of Cologne's Institute of Organic Chemistry, during a recent study, has described a novel method for the enzymatic production of synthetic messenger RNA (mRNA).
Brussels [Belgium], February 18 (ANI): The World Health Organization (WHO) on Friday announced that the first six African countries to receive technologies needed to produce Moderna vaccines will include Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia.